أرباح التشغيل تغيير تاريخ
Adma Biologics USD 52.44M 2.15M 2026-06
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
Eli Lilly USD 12.46B 2.68B 2026-06
Halozyme Therapeutics USD -60.68M 3.04M 2026-09
Insmed USD -81.83M 19.48M 2026-09
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
MacroGenics USD -13.85M 19.59M 2026-06
MannKind USD -59.44M 8.79M 2026-09
Merck USD 7.33B 6.49B 2026-09
Minerva Neurosciences USD -21.85M 17.48M 2024-12
Novavax USD 20.94M 100.32M 2025-12
Novo Nordisk DKK 5.25B 54.37B 2026-06
Pfizer USD 662M 5M 2026-09
Sanofi EUR 4.72B 2.34B 2026-09
Xencor USD -36.6M 41.26M 2026-06